Literature DB >> 8611420

Characterisation of antimitotic products from marine organisms that disorganise the microtubule network: ecteinascidin 743, isohomohalichondrin-B and LL-15.

M García-Rocha1, M D García-Gravalos, J Avila.   

Abstract

The effect of selected marine compounds with anti-tumoral activity on the cell microtubule network was tested by immunofluorescence analyses, or by other in vitro analyses involving competition with colchicine or with GTP for tubulin binding and tubulin polymerisation, studies that were carried out in parallel with other microtubule poisons used as controls. Three compounds were found to disorganise the microtubule network: isohomohalichondrin B, LL-15 and ecsteinascidin 743. The first two compounds prevent microtubule assembly and GTP binding to tubulin. Ecteinascidin 743 disorganises the microtubule network but it does not seem to interact directly with tubulin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611420      PMCID: PMC2075815          DOI: 10.1038/bjc.1996.176

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  Dimethyl sulfoxide-induced self-assembly of tubulin lacking associated proteins.

Authors:  R H Himes; P R Burton; J M Gaito
Journal:  J Biol Chem       Date:  1977-09-10       Impact factor: 5.157

2.  Interaction of oncodazole (R 17934), a new antitumoral drug, with rat brain tubulin.

Authors:  J Hoebeke; G Van Nijen; M De Brabander
Journal:  Biochem Biophys Res Commun       Date:  1976-03-22       Impact factor: 3.575

3.  Properties of colchicine binding protein from chick embryo brain. Interactions with vinca alkaloids and podophyllotoxin.

Authors:  L Wilson
Journal:  Biochemistry       Date:  1970-12-08       Impact factor: 3.162

4.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

5.  Intermediate filaments in 3T3 cells collapse after intracellular injection of a monoclonal anti-intermediate filament antibody.

Authors:  M W Klymkowsky
Journal:  Nature       Date:  1981-05-21       Impact factor: 49.962

6.  Immunofluorescence and immunocytochemical procedures with affinity purified antibodies: tubulin-containing structures.

Authors:  M Osborn; K Weber
Journal:  Methods Cell Biol       Date:  1982       Impact factor: 1.441

7.  Promotion of microtubule assembly in vitro by taxol.

Authors:  P B Schiff; J Fant; S B Horwitz
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

8.  Inhibition of mitosis and anticancer activity against experimental neoplasms by ethyl 5-amino-1,2-dihydro-3-[(N-methylanilino)methyl]-pyrido[3,4-b]pyrazin-7-ylcarbamate (NSC 181928).

Authors:  G P Wheeler; B J Bowdon; J A Werline; D J Adamson; C G Temple
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

9.  Maytansine inhibits nucleotide binding at the exchangeable site of tubulin.

Authors:  A B Huang; C M Lin; E Hamel
Journal:  Biochem Biophys Res Commun       Date:  1985-05-16       Impact factor: 3.575

10.  THE MECHANISM OF COLCHICINE INHIBITION OF MITOSIS. I. KINETICS OF INHIBITION AND THE BINDING OF H3-COLCHICINE.

Authors:  E W TAYLOR
Journal:  J Cell Biol       Date:  1965-04       Impact factor: 10.539

View more
  7 in total

Review 1.  Trabectedin: novel insights in the treatment of advanced sarcoma.

Authors:  Jay Patrick Lopez; Csaba Gajdos; Anthony Elias
Journal:  Curr Oncol Rep       Date:  2014-06       Impact factor: 5.075

Review 2.  Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics.

Authors:  V H Le; M Inai; R M Williams; T Kan
Journal:  Nat Prod Rep       Date:  2015-02       Impact factor: 13.423

3.  Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation.

Authors:  S Jin; B Gorfajn; G Faircloth; K W Scotto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 4.  Mechanism targeted discovery of antitumor marine natural products.

Authors:  Dale G Nagle; Yu-Dong Zhou; Flor D Mora; Kaleem A Mohammed; Yong-Pil Kim
Journal:  Curr Med Chem       Date:  2004-07       Impact factor: 4.530

Review 5.  Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes.

Authors:  Marilia Barreca; Virginia Spanò; Alessandra Montalbano; Mercedes Cueto; Ana R Díaz Marrero; Irem Deniz; Ayşegül Erdoğan; Lada Lukić Bilela; Corentin Moulin; Elisabeth Taffin-de-Givenchy; Filippo Spriano; Giuseppe Perale; Mohamed Mehiri; Ana Rotter; Olivier P Thomas; Paola Barraja; Susana P Gaudêncio; Francesco Bertoni
Journal:  Mar Drugs       Date:  2020-12-04       Impact factor: 5.118

6.  Cell cycle perturbations and apoptosis induced by isohomohalichondrin B (IHB), a natural marine compound.

Authors:  D Bergamaschi; S Ronzoni; S Taverna; M Faretta; P De Feudis; G Faircloth; J Jimeno; E Erba; M D'Incalci
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

Review 7.  Myeloid-derived cells are key targets of tumor immunotherapy.

Authors:  José Medina-Echeverz; Fernando Aranda; Pedro Berraondo
Journal:  Oncoimmunology       Date:  2014-04-15       Impact factor: 8.110

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.